Vitamin D in pediatric patients with obesity and arterial hypertension

Abstract The purpose of this study was to find potential differences in vitamin D levels between different groups: overweight children with hypertension, normal-weight children with hypertension, overweight children with normal blood pressure and normal-weight children without hypertension, represen...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Živa Radulović, Zarja Polak Zupan, Aljoša Tomazini, Nataša Marčun Varda
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/fc30a377eb824401a8f10fc68afedf28
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:fc30a377eb824401a8f10fc68afedf28
record_format	dspace
spelling	oai:doaj.org-article:fc30a377eb824401a8f10fc68afedf282021-12-02T18:51:14ZVitamin D in pediatric patients with obesity and arterial hypertension10.1038/s41598-021-98993-82045-2322https://doaj.org/article/fc30a377eb824401a8f10fc68afedf282021-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-98993-8https://doaj.org/toc/2045-2322Abstract The purpose of this study was to find potential differences in vitamin D levels between different groups: overweight children with hypertension, normal-weight children with hypertension, overweight children with normal blood pressure and normal-weight children without hypertension, representing the control group. We also wanted to determine whether there are correlations between vitamin D levels and other clinical laboratory parameters, to evaluate the potential need for substitution. We measured vitamin D, homocysteine, total cholesterol, HDL, LDL, triglycerides, uric acid, glucose, apolipoprotein A1, apolipoprotein B, alkaline phosphatase, calcium, phosphate and magnesium serum levels in all groups. We also took anthropometric measurements (body weight, height, body mass index (BMI)) and observed patients’ blood pressure. The results were analyzed with SPSS statistic tool with basic statistical methods. The study included 175 children between 5 and 18 years of age. Fiftyseven were healthy (group A—control group), 41 normal-weight with hypertension (group B), 44 overweight with hypertension (group C) and 33 overweight with normal blood pressure (group D). The results showed statistically significant differences in values of vitamin D between all groups—A and B (p = 0.003), A and C (p < 0.001), A and D (p < 0.001), B and D (p = 0.043), B and C (0.030), except for groups C and D (p = 0.830). There were statistically significant correlations between vitamin D and BMI (r = − 0.196, p = 0.010), systolic pressure (r = − 0.190, p = 0.002), diastolic pressure (r = − 0.149, p = 0.050), homocysteine (r = − 0.208, p = 0.007), triglycerides (r = − 0.196, p = 0.011) and apolipoprotein A1 (r = 0.222, p = 0.007), confirmed in multivariate model. For the blood pressure, the higher the systolic blood pressure, the lower the average vitamin D was. The pilot study shows significant differences in serum vitamin D levels between all groups of children, apart from groups C and D. These results, combined with statistically significant correlations between vitamin D and systolic and diastolic blood pressure suggest the need for monitoring and potential substitution of vitamin D in in pediatric patients with hypertension.Živa RadulovićZarja Polak ZupanAljoša TomaziniNataša Marčun VardaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Živa Radulović Zarja Polak Zupan Aljoša Tomazini Nataša Marčun Varda Vitamin D in pediatric patients with obesity and arterial hypertension
description	Abstract The purpose of this study was to find potential differences in vitamin D levels between different groups: overweight children with hypertension, normal-weight children with hypertension, overweight children with normal blood pressure and normal-weight children without hypertension, representing the control group. We also wanted to determine whether there are correlations between vitamin D levels and other clinical laboratory parameters, to evaluate the potential need for substitution. We measured vitamin D, homocysteine, total cholesterol, HDL, LDL, triglycerides, uric acid, glucose, apolipoprotein A1, apolipoprotein B, alkaline phosphatase, calcium, phosphate and magnesium serum levels in all groups. We also took anthropometric measurements (body weight, height, body mass index (BMI)) and observed patients’ blood pressure. The results were analyzed with SPSS statistic tool with basic statistical methods. The study included 175 children between 5 and 18 years of age. Fiftyseven were healthy (group A—control group), 41 normal-weight with hypertension (group B), 44 overweight with hypertension (group C) and 33 overweight with normal blood pressure (group D). The results showed statistically significant differences in values of vitamin D between all groups—A and B (p = 0.003), A and C (p < 0.001), A and D (p < 0.001), B and D (p = 0.043), B and C (0.030), except for groups C and D (p = 0.830). There were statistically significant correlations between vitamin D and BMI (r = − 0.196, p = 0.010), systolic pressure (r = − 0.190, p = 0.002), diastolic pressure (r = − 0.149, p = 0.050), homocysteine (r = − 0.208, p = 0.007), triglycerides (r = − 0.196, p = 0.011) and apolipoprotein A1 (r = 0.222, p = 0.007), confirmed in multivariate model. For the blood pressure, the higher the systolic blood pressure, the lower the average vitamin D was. The pilot study shows significant differences in serum vitamin D levels between all groups of children, apart from groups C and D. These results, combined with statistically significant correlations between vitamin D and systolic and diastolic blood pressure suggest the need for monitoring and potential substitution of vitamin D in in pediatric patients with hypertension.
format	article
author	Živa Radulović Zarja Polak Zupan Aljoša Tomazini Nataša Marčun Varda
author_facet	Živa Radulović Zarja Polak Zupan Aljoša Tomazini Nataša Marčun Varda
author_sort	Živa Radulović
title	Vitamin D in pediatric patients with obesity and arterial hypertension
title_short	Vitamin D in pediatric patients with obesity and arterial hypertension
title_full	Vitamin D in pediatric patients with obesity and arterial hypertension
title_fullStr	Vitamin D in pediatric patients with obesity and arterial hypertension
title_full_unstemmed	Vitamin D in pediatric patients with obesity and arterial hypertension
title_sort	vitamin d in pediatric patients with obesity and arterial hypertension
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/fc30a377eb824401a8f10fc68afedf28
work_keys_str_mv	AT zivaradulovic vitamindinpediatricpatientswithobesityandarterialhypertension AT zarjapolakzupan vitamindinpediatricpatientswithobesityandarterialhypertension AT aljosatomazini vitamindinpediatricpatientswithobesityandarterialhypertension AT natasamarcunvarda vitamindinpediatricpatientswithobesityandarterialhypertension
_version_	1718377482869014528

Vitamin D in pediatric patients with obesity and arterial hypertension

Ejemplares similares